title: Dramatic Antitumor Activity of Nivolumab in Advanced HER2-Positive Lung Cancer.
authors.affiliation: Thoracic Division, Medical Oncology Department, European Institute of Oncology, Milan, Italy. Electronic address: chiara.catania@ieo.it.
authors.forename: Chiara
authors.initials: C
authors.lastname: Catania
authors.affiliation: Thoracic Division, Medical Oncology Department, European Institute of Oncology, Milan, Italy.
authors.forename: Antonio
authors.initials: A
authors.lastname: Passaro
authors.affiliation: Division of Pathology, European Institute of Oncology, Milan, Italy.
authors.forename: Elena Guerini
authors.initials: EG
authors.lastname: Rocco
authors.affiliation: Thoracic Division, Medical Oncology Department, European Institute of Oncology, Milan, Italy.
authors.forename: Gianluca
authors.initials: G
authors.lastname: Spitaleri
authors.affiliation: Division of Pathology, European Institute of Oncology, Milan, Italy.
authors.forename: Massimo
authors.initials: M
authors.lastname: Barberis
authors.affiliation: Thoracic Division, Medical Oncology Department, European Institute of Oncology, Milan, Italy.
authors.forename: Cristina
authors.initials: C
authors.lastname: Noberasco
authors.affiliation: Thoracic Division, Medical Oncology Department, European Institute of Oncology, Milan, Italy.
authors.forename: Ester Del
authors.initials: ED
authors.lastname: Signore
authors.affiliation: Division of Nuclear Medicine, European Institute of Oncology, Milan, Italy.
authors.forename: Laura
authors.initials: L
authors.lastname: Travaini
authors.affiliation: Thoracic Division, Medical Oncology Department, European Institute of Oncology, Milan, Italy.
authors.forename: Filippo
authors.initials: F
authors.lastname: de Marinis
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy* / Q000235:genetics; D000077192:Adenocarcinoma of Lung; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D060890:B7-H1 Antigen / Q000378:metabolism; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000235:genetics; D008207:Lymphatic Metastasis; D008875:Middle Aged; D000077594:Nivolumab; D000072078:Positron Emission Tomography Computed Tomography; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000235:genetics*
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D060890:B7-H1 Antigen; D000077594:Nivolumab; D018719:Erb-b2 Receptor Tyrosine Kinases; C423236:CD274 protein, human; C508053:ERBB2 protein, human
keywords: Activity of nivolumab; Anti-PDL1; ERBB family; Immunotherapy; Lung adenocarcinoma